SOURCE: Perma-Fix Environmental Services, Inc.

Perma-Fix Environmental Services, Inc. Logo

May 18, 2016 10:33 ET

Perma-Fix Environmental Services to Present at B. Riley & Co.'s 17th Annual Investor Conference on May 26

ATLANTA, GA--(Marketwired - May 18, 2016) - Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), today announced that Dr. Louis F. Centofanti, Chairman and Chief Executive Officer of Perma-Fix Environmental Services Inc., will be presenting at the 17th Annual B. Riley & Co. Annual Investor Conference on Thursday, May 26th, 2016 at 2:30 PM Pacific Time. The conference will be held May 25-26, 2016 at Lowes Hollywood Hotel in Los Angeles, California.

About B. Riley & Co.

B. Riley & Co., LLC is a leading investment bank which provides corporate finance, research, and sales & trading to corporate, institutional and high net worth individual clients. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, and merger and acquisitions advisory services. The firm is nationally recognized for its highly ranked proprietary equity research. B. Riley & Co., LLC is a member of FINRA and SIPC. For more information, please visit .

About Perma-Fix Environmental Services

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy ("DOE"), the Department of Defense ("DOD"), and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide.

Through Perma-Fix Medical S.A., our majority-owned Polish subsidiary, we are developing a new process to produce Tc-99m, a widely used medical isotope in the world.

Please visit us on the World Wide Web at

Contact Information

  • Contacts:
    David K. Waldman
    US Investor Relations
    Crescendo Communications, LLC
    (212) 671-1021

    Herbert Strauss
    European Investor Relations
    +43 316 296 316